Site Search
Professionals 672 results
Capabilities 87 results
Industry
Winston’s financial crimes compliance lawyers have been providing regulatory compliance counseling and enforcement services related to the Bank Secrecy Act (BSA), the Anti-Money Laundering Act of 2020 (AML), and countering the financing of terrorism (CFT) policy for decades. We also have experience with international AML matters, including in the EU and with respect to Financial Actions Task Force (FATF) recommendations.
Practice Area
Our team’s deep market knowledge of laws affecting retirement plans enables us to develop customized retirement plan solutions, practical advice, and strategies for our clients’ unique needs and workforce composition. Our experienced benefits attorneys represent public companies, private companies, and private equity operating companies in retirement plan design and day-to-day plan compliance.
Industry
Experience 599 results
Experience
|October 24, 2025
$400 Million GATX Corporation Senior Notes Offering
Represented joint book-running managers BofA Securities, Inc., Citigroup Global Markets Inc., and Morgan Stanley & Co. LLC, as underwriters' counsel, in connection with the registered public offering by GATX Corporation of $200 million of its 5.500% Senior Notes due 2035 and $200 million of its 6.050% Senior Notes due 2054.
Experience
|October 10, 2025
Winston Advises Vistria Affiliate in $136M IPO of Phoenix Education Partners
A Winston & Strawn LLP team led by partners Keerthika Subramanian, Steve Gavin and Timothy Kincaid and including Jacob Tabman, Jeremy Spankowski and Jenna Smith advised TVG-I-E-AEG Holdings, LP, an affiliate of The Vistria Group, as one of the selling stockholders in the $136 million initial public offering of Phoenix Education Partners, Inc. (NYSE: PXED), the parent company of The University of Phoenix, Inc. The IPO valued Phoenix Education Partners, Inc. at approximately $1.35 billion. The transaction marks The University of Phoenix’s return to public markets after nearly a decade as a private company.
Experience
|September 29, 2025
Winston Advises PJT Partners in Beyond Meat’s $1.105 Billion Exchange Offer
Winston & Strawn LLP represented PJT Partners in its role as dealer manager to Beyond Meat, Inc., a publicly traded food technology company and leading producer of plant-based meat alternatives, in connection with an exchange offer and consent solicitation for any and all of its $1.105 billion of 0% Convertible Senior Notes due 2027 for up to $202.5 million in new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and up to approximately 326 million shares of common stock.
Insights & News 8,548 results
Sponsorship
|November 20, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference
Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers South Florida M&A Conference. The conference brings together hundreds of local dealmakers, including middle-market CEOs, top investors and lenders, and leading M&A advisers.
Seminar/CLE
|November 13, 2025
AI in Action: Legal Strategies for Healthcare Innovation
We are bringing together stakeholders across the healthcare ecosystem—from front-line providers to financial backers—for a panel discussion on AI in healthcare.
Sponsorship
|November 12, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers Houston M&A Conference
Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers Houston M&A Conference. The conference will discuss topics ranging from raising capital to alternative asset investing, covering the breadth of the M&A landscape.
Other Results 129 results
Site Content
Also known as maritime cabotage laws, U.S. coastwise laws reserve U.S. domestic maritime trade to qualified U.S. registered (referred to as “U.S.-flag” vessels). These laws are also commonly referred to as the Jones Act. One of these coastwise laws, the Passenger Vessel Services Act, reserves the transportation of passengers between U.S. ports, or points, to qualified U.S.-flag vessels.
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Site Content